DK145892B - PROCEDURE FOR THE PREPARATION OF PYRAZINAMIDE DERIVATIVES - Google Patents

PROCEDURE FOR THE PREPARATION OF PYRAZINAMIDE DERIVATIVES Download PDF

Info

Publication number
DK145892B
DK145892B DK429268AA DK429268A DK145892B DK 145892 B DK145892 B DK 145892B DK 429268A A DK429268A A DK 429268AA DK 429268 A DK429268 A DK 429268A DK 145892 B DK145892 B DK 145892B
Authority
DK
Denmark
Prior art keywords
diamino
alkyl
alkoxyphenyl
mol
phenyl
Prior art date
Application number
DK429268AA
Other languages
Danish (da)
Other versions
DK145892C (en
Inventor
E J Cragoe
K L Shepard
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK145892B publication Critical patent/DK145892B/en
Application granted granted Critical
Publication of DK145892C publication Critical patent/DK145892C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

(19) DANMARK (®)(19) DENMARK (®)

|p (12) FREMLÆGGELSESSKRIFT on 145892 B| p (12) PUBLICATION ON 145892 B

DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM

(21) Ansøgning nr. 4292/68 (51) IntCI.3 C 07 D 2 Λ1 / 2 6 (22) Indleveringsdag 6. s ep. 1968 C 07 D A01/12 (24) Løbedag 6. sep. 1968 C 07 D A03/12 (41) Aim. tilgængelig 8. mar. 1969 (44) Fremlagt 5 · apr · 1 9^5 (86) International ansøgning nr. -(86) International indleveringsdag (85) Videreførelsesdag -(62) Stamansøgning nr. -(21) Application No. 4292/68 (51) IntCI.3 C 07 D 2 Λ1 / 2 6 (22) Filing Day 6. s ep. 1968 C 07 D A01 / 12 (24) Running day Sep 6 1968 C 07 D A03 / 12 (41) Aim. available Mar 8 1969 (44) Submitted 5 · Apr · 1 9 ^ 5 (86) International Application No. - (86) International Filing Day (85) Continuation Day - (62) Stock Application No. -

(30) Prioritet 7. sep. 1967, 666004, US 21. mar. 1968, 718976, US(30) Priority Sep 7 1967, 666004, US Mar 21 1968, 718976, US

(71) Ansøger MERCK & CO. INC., Rahway, US.(71) Applicant MERCK & CO. INC., Rahway, US.

(72) Opfinder Edward Jethro Cragoe Jr., US: Kenneth Leroy Shepard, US.(72) Inventor Edward Jethro Cragoe Jr., US: Kenneth Leroy Shepard, US.

(74) Fuldmægtig Ingeniørfirmaet Hofman-Bang & Boutard.(74) Associate Engineer Hofman-Bang & Boutard.

(54) Fremgangsmåde til fremstilling af pyrazinamidderivater.(54) Process for the preparation of pyrazinamide derivatives.

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af pyrazinamidderivater med den i indledningen til krav 1 angivne almene formel. Denne formel omfatter både kendte og hidtil ukendte forbindelser, der kan benyttes som aktive diure-tiske og natriuretiske midler.The present invention relates to a particular process for the preparation of pyrazinamide derivatives of the general formula set forth in the preamble of claim 1. This formula includes both known and novel compounds which can be used as active diuretic and natriuretic agents.

Hidtil ukendte er forbindelserne med den angivne almene formel, hvori halo betyder chlor, brom eller iod, R° er alkyl, alkoxymeth-^ yl-alkyl, cyano-alkyl, alkoxycarbonylalkyl, phenylalkyl, 2-(2- Π imidazolinyl)-aminomethylalkyl, alkenyl, alkynyl, phenyl, halogen- ° phenyl, alkylphenyl, alkoxyphenyl, amino, di(alkyl)amino, (alkyl- t phenylalkyl)amino, pyridylamino, pyrimidinylamino, quinolinylamino, 4 mTo date, the compounds of the general formula set forth in which halo is chloro, bromo or iodo, R ° is alkyl, alkoxymethylalkyl, cyanoalkyl, alkoxycarbonylalkyl, phenylalkyl, 2- (2- Πimidazolinyl) aminomethylalkyl, alkenyl, alkynyl, phenyl, halo-phenyl, alkylphenyl, alkoxyphenyl, amino, di (alkyl) amino, (alkylphenylalkyl) amino, pyridylamino, pyrimidinylamino, quinolinylamino, 4 m

JJ

2 145892 1-pyrrolidinyl, 1-piperidino, 1-hexahydro-l-azepinyl, 4-morph-olino eller 4- ( 3,5-diamino-l,2,4-triazolyl).1-Pyrrolidinyl, 1-piperidino, 1-hexahydro-1-azepinyl, 4-morpholino or 4- (3,5-diamino-1,2,4-triazolyl).

Ved fremgangsmåden ifølge opfindelsen, der er ejendommelig ved det i den kendetegnende del af krav 1 anførte, benyttes et hidtil ukendt mellemprodukt, nemlig et pyrazinoyloxyacrylamid, der med høj omsætningsgrad reagerer med primære aminer. Denne reaktion kan anskueliggøres ved følgende reaktionsskema: R1 R1^The process according to the invention, which is characterized by the characterizing part of claim 1, uses a novel intermediate, namely a high-conversion pyrazinoyloxyacrylamide which reacts with primary amines. This reaction can be illustrated by the following reaction scheme: R1 R1 ^

Ργν"2 S YTΡγν "2 S YT

halo^ ^ \-0-C=C-C-NHR5+HoNR6 -^ halo /^N'\,_NHR6 o r¥o ohalo ^^ \ -0-C = C-C-NHR5 + HoNR6 - ^ halo / ^ N '\, _ NHR6 o r ¥ o o

I II IIII II III

i hvilke formler R1, R^, R^, r\ R^, og halo har den i krav 1 angivne betydning.in which formulas R 1, R 1, R 2, R 1, R 2 and halo have the meaning set forth in claim 1.

Det er tidligere foreslået at fremstille forbindelser svarende til de ovennævnte pyrazinamider (III) ved omsætning af den pågældende aminoforbindelse og et alkylpyrazinoat. Det har dog vist sig, at disse estere ikke eller kun langsomt reagerer. Hvis man forsøger at fremme reaktionen ved anvendelse af kraftigere reaktionsbetingelser, bliver bireaktionerne dominerende. Derfor har der været et behov for mere reaktionsdygtige derivater af pyrazinsyrer. Det har ifølge opfindelsen overraskende vist sig, at de omhandlede py-razinoyloxyacrylamider er yderst reaktionsdygtige derivater. Reaktionen forløber særlig glat og i højt udbytte ved de i krav 2 karakteriserede reaktionsbetingelser.It has previously been proposed to prepare compounds similar to the above-mentioned pyrazinamides (III) by reaction of the amino compound concerned and an alkyl pyrazinoate. However, it has been found that these esters do not or only slowly react. If one tries to promote the reaction using more powerful reaction conditions, the side reactions become dominant. Therefore, there has been a need for more reactive derivatives of pyrazic acids. According to the invention, it has surprisingly been found that the pyrazinoyloxyacrylamides in question are highly reactive derivatives. The reaction proceeds particularly smoothly and in high yield under the reaction conditions of claim 2.

Udgangsmaterialerne er let tilgængelige, idet de kan fremstilles i overensstemmelse med følgende reaktionsskema: 145892 3 R1 r3 K v. η n N m0 4 R\ * TI ♦ A κξ, .^γ·γ*! „„/ «-' ο» „>y · „„ΛΑ L· £~°~9 = 9-coNHR5 R 8 i3 I4The starting materials are readily available as they can be prepared according to the following reaction scheme: 145892 3 R1 r3 K v. Η n N m0 4 R \ * TI ♦ A κξ,. ^ Γ · γ *! "" / "-" ο ""> y · "" ΛΑ L · £ ~ ° ~ 9 = 9-coNHR5 R 8 i3 I4

IV V IIV V I

12345 hvori R,R,R,R,R og halo har den ovennævnte betydning..12345 wherein R, R, R, R, R and halo have the above meaning.

Omkring ækvivalente mængder pyrazinsyre IV, et isoxazoliumsait V og en tertiær amin opløses i et opløsningsmiddel og omrøres. Eksempler på en egnet amin er en trialkylamin, såsom trimethylamin, triethylamin eller tripropylamin. Som opløsningsmiddel kan hensigtsmæssigt benyttes dimethylformamid, dimethylsulfoxid, dimet-hylsulfon, acetonitril eller tetrahydrofuran, idet dimethylformamid og acetonitril foretrækkes. Først opløses pyrazinsyren og den tertiære amin, idet opløsningen omrøres i et tidsrum mellem 5 minutter og flere timer. Derefter tilsættes isoxazoliumsaltet, og blandingen omrøres i 1 - 4 timer, f.eks. 2 timer ved stuetemperatur, men blandingen kan dog om ønsket opvarmes til 50° C. Produkt I er sædvanligvis så stabilt, at det kan isoleres og renses. Isoleringen sker simpelt ved tilsætning af vand til reaktionsblandingen, hvorved pyrazinoyloxyacrylamid udfældes. I stedet kan produkt (i) fås ved inddampning af reaktionsblandingen. De dannede produkter kan omkrystalliseres, sædvanligvis af et polært organisk opløsningsmiddel, såsom acetonitril eller isopropanol.About equivalent amounts of pyrazinic acid IV, an isoxazolium site V and a tertiary amine are dissolved in a solvent and stirred. Examples of a suitable amine are a trialkylamine such as trimethylamine, triethylamine or tripropylamine. Suitable solvent may be used dimethylformamide, dimethylsulfoxide, dimethylsulfone, acetonitrile or tetrahydrofuran, with dimethylformamide and acetonitrile being preferred. First, the pyrazinic acid and the tertiary amine are dissolved, the solution being stirred for a period of time between 5 minutes and several hours. Then the isoxazolium salt is added and the mixture is stirred for 1 to 4 hours, e.g. 2 hours at room temperature, however, if desired, the mixture may be heated to 50 ° C. Product I is usually so stable that it can be isolated and purified. The isolation occurs simply by adding water to the reaction mixture, whereby pyrazinoyloxyacrylamide precipitates. Instead, product (i) can be obtained by evaporating the reaction mixture. The resulting products can be recrystallized, usually by a polar organic solvent such as acetonitrile or isopropanol.

Det er undertiden en fordel at tandlade at isolere mellemprodukterne, pyrazinoyloxyacrylamiderne, men derimod omdanne dem in situ til de ønskede substituerede pyrazinamider (III). I så tilfælde kan man ca. 1 time efter blandingen af reagenserne IV og V og den tertiære amin tilsætte 1-10 ækvivalenter af aminen (II), og reaktionsblandingen omrøres ved en temperatur fra stuetemperatur indtil 150° C i 2 - 24 timer. Det dannede amid isoleres ved fortynding af reaktionsblandingen med vand eller i nogle tilfælde med en alkohol, såsom ethanol eller isopropylalkohol, som udfælder det ønskede substituerede amid.It is sometimes advantageous to tooth-isolate the intermediates, the pyrazinoyloxyacrylamides, but on the other hand convert them in situ to the desired substituted pyrazinamides (III). In this case, one can approx. 1 hour after the mixture of reagents IV and V and the tertiary amine add 1-10 equivalents of the amine (II) and the reaction mixture is stirred at room temperature to 150 ° C for 2 to 24 hours. The amide formed is isolated by diluting the reaction mixture with water or in some cases with an alcohol such as ethanol or isopropyl alcohol which precipitates the desired substituted amide.

145892 4145892 4

Hvis det er hensigtsmæssigt først af isolere pyra”inoyloxyacryl-amiderne (I), udføres reaktionen som ovenfor beskrevet med den ændring, at det forud dannede mellemprodukt (i) og aminoforbin-delsen (II) blandes i et molært forhold på mellem 1:1 og 1:10 i et opløsningsmiddel, såsom dimethylformamid, dioxan, dichlor-methan, tetrahydrofuran, acetonitril eller t-butanol, fortrinsvis tetrahydrofuran eller acetonitril, og blandingen omrøres fra 2 til 24 timer mellem stuetemperatur og kogepunktet. Reaktionstid og -temperatur afhænger af reagensernes art.If it is convenient to first isolate the pyra 'inoyloxyacrylamides (I), the reaction is carried out as described above with the change that the precursor intermediate (i) and the amino compound (II) are mixed in a molar ratio of 1: 1. and 1:10 in a solvent such as dimethylformamide, dioxane, dichloromethane, tetrahydrofuran, acetonitrile or t-butanol, preferably tetrahydrofuran or acetonitrile, and the mixture is stirred for 2 to 24 hours between room temperature and the boiling point. Reaction time and temperature depend on the nature of the reagents.

Pyrazinsyrerne kan fremstilles ved hydrolyse af de tilsvarende methylestere (VI) som vist nedenfor. Hydrolysen kan udføres med en vandig base, såsom natriumhydroxid eller kaliumhydroxid, og et opløsningsmiddel, såsom isopropanol eller ethanol, og blandingen koges i 1 - 10 timer. Pyrazinsyren isoleres derefter ved afkøling og tilsætning af syre, såsom saltsyre eller svovlsyre.The pyrazic acids can be prepared by hydrolysis of the corresponding methyl esters (VI) as shown below. The hydrolysis can be carried out with an aqueous base such as sodium hydroxide or potassium hydroxide and a solvent such as isopropanol or ethanol and the mixture is boiled for 1 to 10 hours. The pyrazinic acid is then isolated by cooling and adding acid, such as hydrochloric or sulfuric acid.

NS\ ^NS \ ^

halo C00CH, halo/ C00Hhalo C00CH, halo / C00H

33

VI IVVI IV

Fremgangsmåden ifølge opfindelsen illustreres ved de følgende eksempler.The process of the invention is illustrated by the following examples.

EKSEMPEL_1 N-Ethvl-3.5-diamino-6-chlorpyrazinamid N-(t-Butyl)-3-methyl-3-(3,5-diamino-6-chlorpyrazinoyloxy)acryl-amid (0,10 g, 0,3 mol) opløses i et minimum af tetrahydrofuran.EXAMPLE_1 N-Ethyl-3,5-diamino-6-chloropyrazinamide N- (t-Butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (0.10 g, 0.3 mole) ) is dissolved in a minimum of tetrahydrofuran.

En 70 $ vandig ethylaminopløsning (1,0 ml) tilsættes, og opløsningen koges i 4 minutter. Opløsningen inddampes under reduceret tryk, og remanensen behandles med vand (5 ml). Ved henstand udkrystalliserer et fast stof, der opsamles og tørres, 0,05 g (769é)., smp: 204 - 6° C. Ved omkrystallisation af benzen fås N-ethyl- 3,5-diamino-6-chlorpyrazinamid, der smelter ved 205 - 206° C.A 70 $ aqueous ethylamine solution (1.0 ml) is added and the solution is boiled for 4 minutes. The solution is evaporated under reduced pressure and the residue is treated with water (5 ml). On standing, a solid which is collected and dried crystallizes 0.05 g (769 e), mp: 204 - 6 ° C. Recrystallization of benzene gives N-ethyl-3,5-diamino-6-chloropyrazinamide which melts at 205 - 206 ° C.

5 U58325 U5832

Analyse beregnet for CyH^øClN^O: C 38,98, Η 4,67, N 32,48.Calcd for CyH 2 ClCl 2 O: C 38.98, Η 4.67, N 32.48.

Fundet: C 38,65, H 4,60, N 33,28.Found: C, 38.65; H, 4.60; N, 33.28.

EKSEMPEL_2 N-Ethoxycarbonylmethvl-5,5-diamino-6-chlorpyrazinamidEXAMPLE 2 N-Ethoxycarbonylmethyl-5,5-diamino-6-chloropyrazinamide

Ethylglycinat-hydrochlorid (5,60 g, 0,04 mol) opløses i en blanding af vand (50 ml) og natriumbicarbonat (5,0 g, 0,06 mol). En opløsning af N-(t-butyl)-3-methyl-3-(3,5-diamino-6-chlorpyrazin-oyloxy)acrylamid (3,27 g, 0,01 mol) i tetrahydrofuran (100 ml) tilsættes, og blandingen opvarmes på dampbad i 2 timer. Vand (500 ml) tilsættes, og opløsningen afkøles. Det faste bundfald opsamles og tørres, 2,17 g (80 %), smp: 172 - 174°C. Efter omkrystallisation af isopropanol smelter N-ethoxycarbonylmethyl-3,5-diamino-6-chlorpyrazinamidet ved 174 - 175° C.Ethyl glycinate hydrochloride (5.60 g, 0.04 mol) is dissolved in a mixture of water (50 ml) and sodium bicarbonate (5.0 g, 0.06 mol). A solution of N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazine oyloxy) acrylamide (3.27 g, 0.01 mole) in tetrahydrofuran (100 ml) is added, and the mixture is heated on a steam bath for 2 hours. Water (500 ml) is added and the solution is cooled. The solid precipitate is collected and dried, 2.17 g (80%), mp: 172 - 174 ° C. After recrystallization from isopropanol, the N-ethoxycarbonylmethyl-3,5-diamino-6-chloropyrazinamide melts at 174 - 175 ° C.

Analyse beregnet for CgH12ClN503: C 39,49, H 4,42, N 25,59.Analysis calculated for C 9 H 12 ClN 5 O 3: C 39.49, H 4.42, N 25.59.

Fundet: C 39,77, H 4,38, N 25,45.Found: C 39.77, H 4.38, N 25.45.

EKSEMPEL_3 N-(2-Morpholinoethyl)-3,5-diamino-6-chlorpyrazinamidEXAMPLE 3 N- (2-Morpholinoethyl) -3,5-diamino-6-chloropyrazinamide

En opløsning af N-(t-butyl)-3-methyl-3-(3,5-diamino-6-chlorpyra-zinoyloxy)acrylamid (3,27 g, 0,01 mol) og 2-morpholinoethylamin, (1,50 g, 0,0115 m), i tetrahydrofuran koges i 2 timer. Tetrahy-drofuranet afdampes under reduceret tryk, og remanensen suspenderes i hexan (40 ml) og filtreres, 3,0 g (100 %), smp: 153 -166°C. Ved omkrystallisation af N-(2-morpholin'oethyl)-3,5-dia-mino-6-chlorpyrazinamidet af absolut ethanol hæves smeltepunktet til 178 - 180°c.A solution of N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (3.27 g, 0.01 mole) and 2-morpholinoethylamine, (1, 50 g, 0.0115 m) in tetrahydrofuran are boiled for 2 hours. The tetrahydrofuran is evaporated under reduced pressure and the residue is suspended in hexane (40 ml) and filtered, 3.0 g (100%), mp: 153 -166 ° C. By recrystallization of the N- (2-morpholinoethyl) -3,5-diamino-6-chloropyrazinamide of absolute ethanol, the melting point is raised to 178-180 ° C.

Analyse beregnet for cnHi7C1N6°2: c ^3,93, H 5,70, N 27,95.Analysis calculated for c11 H17 ClN6 ° 2: c3 3.93, H 5.70, N 27.95.

Fundet: C 44,22, H 5,68, N 27,84.Found: C 44.22, H 5.68, N 27.84.

... 6 '· 145892 - EKSEMPEL 4 N-Phenvl-5.5-diamino-6-chlorpyrazinamidEXAMPLE 4 N-Phenyl-5,5-Diamino-6-chloropyrazinamide

En blanding af N- (t-butyl)-3-methyl-3- (3,5-diamino-6-chlorpyra-zinoyloxy)acrylamid (3,27 g, 0,01 mol),, anilin (4,65 g, 0,05 mol) og n-amylalkohol (20 ml) opvarmes til reflux. Den dannede opløsning koges i 24 timer og filtreres varmt til fjernelse af noget uopløseligt stof. Filtratet inddampes under reduceret tryk, og den olieagtige remanens opløses i dichlormethan (50 ml). Denne opløsning ekstrahere s med 1 n saltsyre (to 20 ml portioner), dichlor-methanen tørres over vandfrit magnesiumsulfat og inddampes derefter under reduceret tryk. Remanensen udrives med butylchlorid, hvorved fås 0,30 g N-phenyl-3,5-diamino-6-chlorpyrazinamid, smp: 193 1970C. Efter omKrystallisation af cyclohexan smelter produk tet ved 198 - 202° C.A mixture of N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (3.27 g, 0.01 mole), aniline (4.65 g , 0.05 mole) and n-amyl alcohol (20 ml) are heated to reflux. The resulting solution is boiled for 24 hours and filtered hot to remove any insoluble matter. The filtrate is evaporated under reduced pressure and the oily residue is dissolved in dichloromethane (50 ml). This solution extracts s with 1N hydrochloric acid (two 20 ml portions), dichloromethane is dried over anhydrous magnesium sulfate and then evaporated under reduced pressure. The residue is triturated with butyl chloride to give 0.30 g of N-phenyl-3,5-diamino-6-chloropyrazinamide, mp: 193 ° C. After recrystallization from cyclohexane, the product melts at 198 - 202 ° C.

Analyse beregnet for C^H^qCIN^O: C 50,10, H 3,82, N 26,56.Analysis calculated for C CH H qClN ^O: C 50.10, H 3.82, N 26.56.

Fundet: C 49,98, H 3,84, N 26,39.Found: C 49.98, H 3.84, N 26.39.

EKSEMPEL 5 3.5-Diamino-6-chlorpyrazinsyre. 2.2-tetramethylenhydrazidExample 5 3.5-Diamino-6-chloropyrazinic acid. 2,2-tetramethylenhydrazid

En blanding af 1-aminopyrrolidin (2,15 g, 0,025 mol), N-(t-butyl)- 3-methyl-3-(3,5-diamino-6-chlorpyrazinoyloxy)acrylamid (6,56 g, 0,02 mol) og acetonitril (100 ml) opvarmes under reflux i 2 timer.A mixture of 1-aminopyrrolidine (2.15 g, 0.025 mol), N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (6.56 g, O (2 ml) and acetonitrile (100 ml) are heated under reflux for 2 hours.

Det udfældede stof opsamles og tørres, 3,45 g (67 %), smp. 222 -224,5°C. Ved omkrystallisation af acetonitril fås 3,5-diamino-6-chlor-pyrazinsyre, 2,2-tetramethylenhydrazid, smp: 224 - 225,5°c.The precipitate is collected and dried, 3.45 g (67%), m.p. 222-224.5 ° C. Recrystallization from acetonitrile gives 3,5-diamino-6-chloro-pyrazinic acid, 2,2-tetramethylene hydrazide, mp: 224 - 225.5 ° C.

Analyse beregnet for C^H-^ClNgO: C 42,11, H 5,10, N 32,74.Analysis calculated for C C CH ClClNgO: C 42.11, H 5.10, N 32.74.

Fundet: C 42,44, H 4,88, N 32,38.Found: C 42.44, H 4.88, N 32.38.

EKSEMPEL_6 7 145892 3.5- Diamino-6-chlorpyrazinsyre. 2-(2-pyridvl)hvdrazidEXAMPLE 6 Diamino-6-chloropyrazinic acid. 2- (2-pyridyl) hydrazide

En blanding af 2-hydrazinpyridin (2,18 g, 0,02 mol), N-(t-butyl)- 3-methyl-3-(3,5-diamino-6-chlorpyrazinoyloxy)acrylamid (3.39 g, 0,01 mol) og acetonitril (75 ml) opvarmes under reflux i 3 timer.A mixture of 2-hydrazine pyridine (2.18 g, 0.02 mol), N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (3.39 g, O 01 mol) and acetonitrile (75 ml) are heated under reflux for 3 hours.

Det udfældede stof opsamles og tørres, 2,21 g (79 %), smp: 283 -286°C, dek. Denne prøve renses yderligere ved opløsning af fortyndet methansulfonsyre og genudfældning ved tilsætning af 10 % natriumhydroxid-opløsning, hvorved fås 3,5-diamino-6-chlor-py-razinsyre, 2-(2-pyridyl)hydrazid, smp: 286 - 290°C, dek..The precipitate is collected and dried, 2.21 g (79%), mp: 283 -286 ° C, dec. This sample is further purified by dissolving dilute methanesulfonic acid and re-precipitating by adding 10% sodium hydroxide solution to give 3,5-diamino-6-chloro-pyrazinic acid, 2- (2-pyridyl) hydrazide, mp: 286-290 ° C, dec ..

Analyse beregnet for cioH10C1N70: C 42,94, H 3,60, N 35,00.Analysis calculated for C10 H10 ClN3 O: C 42.94, H 3.60, N 35.00.

Pundet: C 42,74, H 3,96, N 34,75.Pound: C 42.74, H 3.96, N 34.75.

EKSEMPEL 7 3.5- Diamino-6-chlorpyrazinsyre,2-(2-pyrimidinyl)-hydrazidhvdratEXAMPLE 7 3.5 - Diamino-6-chloropyrazinic acid, 2- (2-pyrimidinyl) hydrazide hydrate

En blanding af 3,5-diamino-6-chlorpyrazinsyre (l,90 g, 0,01 mol) og triethylamin (1,0 g, 0,01 mol) i dimethylformamid (20 ml) omrøres i 10 minutter. Til denne opløsning sættes N-(t-butyl)-5-methylisoxazolium-perchlorat (2,40 g, 0,01 mol), og den dannede opløsning omrøres i 1 time. En opløsning af 2-hydrazinopyrimidin (4,40 g, 0,04 mol) i dimethylformamid (20 ml) tilsættes, opløsningen omrøres i 4 timer og opvarmes derefter på dampbad i 3 timer. Vand (200 ml) tilsættes, og det udfældede stof opsamles og tørres. Udbyttet er 2,25 g (80,5 %), smp: 257 - 260° C. Omkrystallisation af 80 % acetonitril giver lysegule krystaller, smp: 262 -263°C af 3,5-diamino-6-chlorpyrazinsyre, 2-(2-pyrimidinyljhydrazid-hydrat.A mixture of 3,5-diamino-6-chloropyrazinic acid (1.90 g, 0.01 mole) and triethylamine (1.0 g, 0.01 mole) in dimethylformamide (20 ml) is stirred for 10 minutes. To this solution is added N- (t-butyl) -5-methylisoxazolium perchlorate (2.40 g, 0.01 mol) and the resulting solution is stirred for 1 hour. A solution of 2-hydrazinopyrimidine (4.40 g, 0.04 mol) in dimethylformamide (20 ml) is added, the solution is stirred for 4 hours and then heated on a steam bath for 3 hours. Water (200 ml) is added and the precipitate is collected and dried. The yield is 2.25 g (80.5%), mp: 257-260 ° C. Recrystallization from 80% acetonitrile gives pale yellow crystals, mp: 262-226 ° C of 3,5-diamino-6-chloropyrazinic acid, 2- (2-pyrimidinyljhydrazid hydrate.

Analyse beregnet for C^H^dN^O.HgO: C 36,19, H 3,71, N 37,52.Analysis calculated for C C HH ^NNO₂H₂O: C 36.19, H 3.71, N 37.52.

Pundet: C 36,18, H 3,75, N 37,74.Pound: C 36.18, H 3.75, N 37.74.

EKSEMPEL 8 5♦5-Diamlno-6-chlorpyrazinsyre. 2,2-hexamethvlenhydrazid 8 145892EXAMPLE 8 5 ♦ 5-Diamino-6-chloropyrazinic acid. 2,2-hexamethylene hydrazide 8 145892

En opløsning af 1-aminohomopiperidin (4,56 g, 0,04 mol) og N-(t-butyl)-3-methyl-3-(3,5-diamino-6-chlorpyrazinoyloxy)acrylamid (3,28 g, 0,01 mol) i tetrahydrofuran (50 ml) koges i 24 timer. Opløsningsmidlet afdampes under reduceret tryk, og den olieag-tige remanens opløses i isopropanol (100 ml). Ved afkøling udskilles et stof, som opsamles og tørres, 1,06 g (37%), smp: 181 ” 1S0°C. Ved omkrystallisation af acetonitril fås 3,5-dia-mino-6-chlorpyrazinsyre, 2,2-hexamethylenhydrazid, smp: 190 -192° C.A solution of 1-aminohomopiperidine (4.56 g, 0.04 mol) and N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (3.28 g, 0.01 mol) in tetrahydrofuran (50 ml) is boiled for 24 hours. The solvent is evaporated under reduced pressure and the oily residue is dissolved in isopropanol (100 ml). On cooling, a substance which is collected and dried is 1.06 g (37%), mp: 181 ”1S0 ° C. Recrystallization from acetonitrile yields 3,5-diamino-6-chloropyrazinic acid, 2,2-hexamethylene hydrazide, mp: 190 -192 ° C.

Analyse beregnet for C^E^ClNgO: C 46,39, H 6,02, N 29,52.Analysis calculated for C C ^H ClClNgO: C 46.39, H 6.02, N 29.52.

Pundet: C 46,80, H 5,85, N 29,96.Pound: C 46.80, H 5.85, N 29.96.

EKSEMPEL 9 3.5- Diamino-6-chlorpyrazinsvre. 2.2-pentamftt.h vi pnhvrtr-* ? -i ήEXAMPLE 9 3.5- Diamino-6-chloropyrazinic acid. 2.2-pentamftt.h we pnhvrtr- *? -i ή

En blanding af 3,5-diamino-6-chlorpyrazinsyre (3,80 g, 0,02 mol) og triethylamin (2,0 g, 0,02 mol) i dimethylformamid (40 ml) omrøres i 10 minutter. Til denne opløsning sættes N-(t-butyl)-5-methylisoxazolium-perchlorat (4,80 g, 0,02 mol), og den dannede opløsning omrøres i 1 time. 1-Aminopiperidin (5,2 g, 0,52 mol) tilsættes, og opløsningen opvarmes på dampbad i 4 timer. Isopropanol (25Ο ml) tilsættes, og det faste stof, som fraskilles ved afkøling og tørres, 2,22 g (41 %), smp: 238 - 243°C. Ved omkrystallisation af acetonitril fås gule krystaller af 3,5-diami-no-6-chlorpyrazinsyre, 2,2-pentamethylenhydrazid, smp: 244 - 245°c.A mixture of 3,5-diamino-6-chloropyrazinic acid (3.80 g, 0.02 mol) and triethylamine (2.0 g, 0.02 mol) in dimethylformamide (40 ml) is stirred for 10 minutes. To this solution is added N- (t-butyl) -5-methylisoxazolium perchlorate (4.80 g, 0.02 mol) and the resulting solution is stirred for 1 hour. 1-Aminopiperidine (5.2 g, 0.52 mol) is added and the solution is heated on a steam bath for 4 hours. Isopropanol (25Ο ml) is added and the solid, which is separated by cooling and dried, 2.22 g (41%), mp: 238 - 243 ° C. Recrystallization from acetonitrile gives yellow crystals of 3,5-diamino-6-chloropyrazinic acid, 2,2-pentamethylene hydrazide, mp: 244 - 245 ° C.

Analyse beregnet for C^QH^ClNgO: C 44,36, H 5,59, N 31,05.Analysis calculated for C C CH ^ClNgO: C 44.36, H 5.59, N 31.05.

Fundet: C 44,52, H 5,28, N 31,37.Found: C 44.52, H 5.28, N 31.37.

EKSEMPEL_12 3.5- Diamino-4-(3,5-diamino-6-chlorpyrazinamido)-4H-l,2,4-triazol-hemihydrat 9 146892EXAMPLE_12 3.5- Diamino-4- (3,5-diamino-6-chloropyrazinamido) -4H-1,2,4-triazole hemihydrate

En blanding af 3,5-diamino-6-chlorpyrazinsyre (1,90 g, 0,01 mol) og triethylamin (1,0 g, 0,01 mol) i dimethylformamid (20 ml) omrøres i 10 minutter. Til denne opløsning sættes N-(t-butyl)-5-methylisoxazolium-perchlorat (2,40 g, 0,01 mol), og den dannede opløsning omrøres i 1 time. En blanding af 3,4,5-triamino-4H-1,2,4-triazol (3,06 g, 0,03 mol) og dimethylformamid (10 ml) tilsættes, og reaktionsblandingen opvarmes på dampbad i 16 timer.A mixture of 3,5-diamino-6-chloropyrazinic acid (1.90 g, 0.01 mole) and triethylamine (1.0 g, 0.01 mole) in dimethylformamide (20 ml) is stirred for 10 minutes. To this solution is added N- (t-butyl) -5-methylisoxazolium perchlorate (2.40 g, 0.01 mol) and the resulting solution is stirred for 1 hour. A mixture of 3,4,5-triamino-4H-1,2,4-triazole (3.06 g, 0.03 mol) and dimethylformamide (10 ml) is added and the reaction mixture is heated on a steam bath for 16 hours.

Vand (200 ml) tilsættes, og det dannede bundfald opsamles og tørres; udbytte 1,50 g (51 %), gradvis dekomposition over 200° C.Water (200 ml) is added and the resulting precipitate is collected and dried; yield 1.50 g (51%), gradual decomposition above 200 ° C.

Ved omkrystallisation af vand fås brune krystaller af 3,5-diami-no-4-(3,5“diamino-6-chlorpyrazinamido)-4H-1,2,4-triazol-hemihy-drat, smp: 275 - 280°c, dek..Recrystallization of water gives brown crystals of 3,5-diamino-4- (3,5 "diamino-6-chloropyrazinamido) -4H-1,2,4-triazole hemihydrate, mp: 275-280 ° c, deck ..

Analyse beregnet for C7HgClN1()0.l/2H20: C 28,63, H 3,43, N 47,70. Fundet: C 28,58, H 3,37, N 47,45.Analysis calculated for C 7 H 9 ClN 1 () 0. 1 / 2H 2 O: C 28.63, H 3.43, N 47.70. Found: C 28.58, H 3.37, N 47.45.

EKSEMPEL_11 N-(3.5-Diamino-6-chlorpyrazinoyl)benzamidinEXAMPLE_11 N- (3,5-Diamino-6-chloropyrazinoyl) benzamidine

Natriumhydroxid (1,20 g, 0,03 mol) opløses i vand (30 ml), og benzamidin-hydrochlorid (5,60 g, 0,036 mol) tilsættes. Denne opløsning omrøres i to minutter, N-(t-butyl)-3-methyl-3-(3,5-dia-mino-6-chlorpyrazinoyloxy)acrylamid (3,28 g, 0,01 mol) tilsættes, og blandingen omrøres i 2 timer. Bundfaldet opsamles, tørres og omkrystalliseres af acetonitril, hvorved fås 0,83 g (29 %) smp: 220 - 224°C, dek.. Ved omkrystallisation af ethanol-acetoni-tril fås N-(3,5-diamino-6-chlorpyrazinoyl)benzamidin, smp: 221 -224° C, dek..Sodium hydroxide (1.20 g, 0.03 mol) is dissolved in water (30 ml) and benzamidine hydrochloride (5.60 g, 0.036 mol) is added. This solution is stirred for two minutes, N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (3.28 g, 0.01 mol) is added and the mixture stir for 2 hours. The precipitate is collected, dried and recrystallized from acetonitrile to give 0.83 g (29%) mp: 220 - 224 ° C, dec. On recrystallization from ethanol-acetonitrile, N- (3,5-diamino-6- chlorpyrazinoyl) benzamidine, mp: 221 -224 ° C, dec.

Analyse beregnet for C^gH^ClNgO: C 49,57, H 3,81, N 28,91*Analysis calculated for C C ^H ^ClNgO: C 49.57, H 3.81, N 28.91 *

Fundet: C 49,95, H 3,90, N 29,12.Found: C 49.95, H 3.90, N 29.12.

EKSEMPEL 12 (3.5-Diamino-6-chlorpvrazinovl)guanidin-hydrochlorid-dihvdratEXAMPLE 12 (3,5-Diamino-6-chloropyrrazinyl) guanidine hydrochloride dihydrate

En blanding af 3,5-diamino-6-chlorpyrazinsyre (1,90 g, 0,01 mol) og triethylamin (1,0 g, 0,01 mol) i dimethylformamid (20 ml) om- 10 1Λ5892 røres i 10 minutter. N-(t-butyl)-5Hnethylisoxazolium-perchlorat (2,40 g, 0,01 mol) tilsættes, og den dannede opløsning omrøres i 1 time.A mixture of 3,5-diamino-6-chloropyrazinic acid (1.90 g, 0.01 mole) and triethylamine (1.0 g, 0.01 mole) in dimethylformamide (20 ml) is stirred for 10 minutes. . N- (t-butyl) -5-methylisoxazolium perchlorate (2.40 g, 0.01 mol) is added and the resulting solution is stirred for 1 hour.

Natrium (1,15 g, 0,05 mol) opløses i absolut ethanol (50 ml). Guanidin-hydrochlorid (4,75 g, 0,05 mol) tilsættes, og blandingen omrøres i l/2 time. Blandingen filtreres, og filtratet inddampes under reduceret tryk. Remanensen opløses i dimethylform-amid (10 ml) og sættes til ovennævnte opløsning. Denne reaktionsblanding omrøres i 24 timer, hældes i vand (100 ml) og afkøles. Bundfaldet opsamles og tørres. Udbyttet er 0,88 g, smp: 229 -233° C,dek..Sodium (1.15 g, 0.05 mole) is dissolved in absolute ethanol (50 ml). Guanidine hydrochloride (4.75 g, 0.05 mol) is added and the mixture is stirred for 1/2 hour. The mixture is filtered and the filtrate is evaporated under reduced pressure. The residue is dissolved in dimethylformamide (10 ml) and added to the above solution. This reaction mixture is stirred for 24 hours, poured into water (100 ml) and cooled. The precipitate is collected and dried. The yield is 0.88 g, mp: 229 -233 ° C, dec.

Produktet opløses i en blanding af vand (15 ml) og methansulfon-syre (2 ml) ved opvarmning, koncentreret saltsyre (4 ml) tilsættes, og opløsningen henstilles. Det udfældede stof opsamles og tørres. Udbyttet af (3,5-diamino-6-chlorpyrazinoyl)gUanidin-hy-drochloriddihydrat er 36 %, smp: 295° C, (dek.). Dette stof opfører sig på samme måde ved kromatografiske undersøgelser, har samme infrarøde spektra som en på anden måde fremstillet prøve, samt udviser ingen frysepunktsdepression med en sådan prøve.The product is dissolved in a mixture of water (15 ml) and methanesulfonic acid (2 ml) by heating, concentrated hydrochloric acid (4 ml) is added and the solution is left to stand. The precipitated substance is collected and dried. The yield of (3,5-diamino-6-chloropyrazinoyl) guanidine hydrochloride dihydrate is 36%, mp: 295 ° C (dec.). This substance behaves similarly to chromatographic studies, has the same infrared spectra as a otherwise prepared sample, and exhibits no freezing-point depression with such a sample.

EKSEMPEL_13 3.5-Diamino-6-chlorpYrazinoylguanidin-hydrochlorid-dihydratEXAMPLE_13 3,5-Diamino-6-chloropyrazinoylguanidine hydrochloride dihydrate

Natrium (0,09 g, 0,004 mol) opløses i absolut ethanol (10 ml), og guanidin-hydrochlorid (0,382 g, 0,004 mol) tilsættes. Denne blanding omrøres l/2 time, N-(t-butyl)-3-methyl-3-(3,5-diamino- 6-chlorpyrazinoyloxy)acrylamid (0,300 g, 0,0009 mol) tilsættes, og blandingen koges i 1 time. Reaktionsblandingen afkøles, fortyndes med vand (25 ml) og gøres sur med fortyndet saltsyre. Ved henstand udskilles et bundfald, som opsamles og tørres, hvorved fås 0,15 g (60 %), (3>5-diamino-6-chlorpyrazinoyl)guanidin-hy-drochlorid-dihydrat smp: 295° C (dek.).Sodium (0.09 g, 0.004 mol) is dissolved in absolute ethanol (10 ml) and guanidine hydrochloride (0.382 g, 0.004 mol) is added. This mixture is stirred 1/2 hour, N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (0.300 g, 0.0009 mol) is added and the mixture is boiled for 1 hour. hour. The reaction mixture is cooled, diluted with water (25 ml) and acidified with dilute hydrochloric acid. Upon standing, a precipitate is collected which is collected and dried to give 0.15 g (60%) of (3> 5-diamino-6-chloropyrazinoyl) guanidine hydrochloride dihydrate mp: 295 ° C (dec).

1-(5.5-Diamino-6-chlorpyrazinovl)-5-isopropylidenaminoguanidin EKSEMPEL 14 11 US8921- (5,5-Diamino-6-chloropyrazinyl) -5-isopropylidene aminoguanidine EXAMPLE 14 11 US892

En blanding af 3,5-diamino-6-chlorpyrazinsyre (3,80 g, 0,02 mol) og triethylamin (2,0 g, 0,02 mol) i dimethylformamid (40 ml) omrøres i 10 minutter. Til denne opløsning sættes N-(t-butyl)-5-methylisoxazolium-perchlorat (4,80 g, 0,02 mol), og den dannede opløsning omrøres i 1 time. En opløsning af isopropylidenamino-guanidin (9,12 g, 0,08 mol) i dimethylformamid (20 ml) tilsættes, og reaktionsblandingen omrøres ved stuetemperatur i 18 timer.A mixture of 3,5-diamino-6-chloropyrazinic acid (3.80 g, 0.02 mol) and triethylamine (2.0 g, 0.02 mol) in dimethylformamide (40 ml) is stirred for 10 minutes. To this solution is added N- (t-butyl) -5-methylisoxazolium perchlorate (4.80 g, 0.02 mol) and the resulting solution is stirred for 1 hour. A solution of isopropylideneamino guanidine (9.12 g, 0.08 mol) in dimethylformamide (20 ml) is added and the reaction mixture is stirred at room temperature for 18 hours.

Vand (250 ml) tilsættes, og det udfældede stof opsamles og tørres. Udbyttet af l-(3,5-diamino-6-chlorpyrazinoyl)3-isopropyli-denaminoguanidin er 4,35 g (76 %); smp: 171 - 178°c. Ved omkry-stallisation af acetonitril fås lysegule krystaller, smp: 183 -186°C.Water (250 ml) is added and the precipitate is collected and dried. The yield of 1- (3,5-diamino-6-chloropyrazinoyl) 3-isopropyl-denaminoguanidine is 4.35 g (76%); mp: 171 - 178 ° c. Recrystallization from acetonitrile gives pale yellow crystals, mp: 183 -186 ° C.

Analyse beregnet for CgH^ClNgO: C 37,96, H 4,60, N 39,36.Analysis calculated for C CHHClNgO: C 37.96, H 4.60, N 39.36.

Fundet: C 38,01, H 4,65, N 39,15.Found: C, 38.01; H, 4.65; N, 39.15.

EKSEMPEL 15 l-(5.5-Diamino-6-chlorpyrazinoyl)-3-hydroxyguanidinExample 15 1- (5,5-Diamino-6-chloropyrazinoyl) -3-hydroxyguanidine

Natrium (1,0 g, 0,044 mol) opløses i kogende isopropanol (200 ml). Hydroxyguanidin-sulfat-hydrat (6,38 g, 0,024 mol) tilsættes, og denne blanding koges i 1 time. N-(t-butyl)-3-methyl-3-(3,5-di-amino-6-chlorpyrazinoyloxy)acrylamid (6,54 g, 0,02 mol) tilsættes, kogningen fortsættes i 1 time, hvorefter blandingen afkøles og filtreres. Det gule stof vaskes med vand og isopropanol og tørres, hvorved fås 2,75 g (56 %), l-(3,5-diamino-6-chlorpyrazinoyl)- 3-hydroxyguanidin, smp: 188 - 200° C (effervescens). Ved omkrystallisation af dimethylformamid-vand fås et produkt med smp: 200 - 202° C (dek.).Sodium (1.0 g, 0.044 mol) is dissolved in boiling isopropanol (200 ml). Hydroxyguanidine sulfate hydrate (6.38 g, 0.024 mol) is added and this mixture is boiled for 1 hour. N- (t-butyl) -3-methyl-3- (3,5-di-amino-6-chloropyrazinoyloxy) acrylamide (6.54 g, 0.02 mol) is added, boiling is continued for 1 hour, then the mixture is cooled and filtered. The yellow substance is washed with water and isopropanol and dried to give 2.75 g (56%) of 1- (3,5-diamino-6-chloropyrazinoyl) -3-hydroxyguanidine, mp: 188 - 200 ° C (effervescence) . Recrystallization of dimethylformamide-water gives a product, mp: 200-202 ° C (dec).

Analyse beregnet for CgHgClNy02: C 29,34, H 3,28, N 39,92.Analysis calculated for C CHgClNyO₂: C 29.34, H 3.28, N 39.92.

Fundet: C 29,42, H 3,25, N 40,01.Found: C 29.42, H 3.25, N 40.01.

12 1-(3,5-Diamino-6-chlorpyrazinoyl)-5-benzyloxyguanldin12 1- (3,5-Diamino-6-chloropyrazinoyl) -5-benzyloxyguanldine

EKSEMPELVISPREVIEW

145892145892

En opløsning af N-(t-butyl)-3-methyl-3-(3,5-diamino-6-chlorpyra-zinoyloxy)acrylamid (1,08 g, 0,0033 mol) og benzyloxyguanidin (1,1 g, 0,0067 mol) i tetrahydrofuran (30 ml) koges i 48 timer. Opløsningen inddampes under reduceret tryk, og isopropanol (20 ml) sættes til remanensen. Det faste stof opsamles og tørres, 0,95 g, smp: 105 - 110° C, stivner atter og smelter igen ved ca.A solution of N- (t-butyl) -3-methyl-3- (3,5-diamino-6-chloropyrazinoyloxy) acrylamide (1.08 g, 0.0033 mol) and benzyloxyguanidine (1.1 g, 0.0067 mol) in tetrahydrofuran (30 ml) is boiled for 48 hours. The solution is evaporated under reduced pressure and isopropanol (20 ml) is added to the residue. The solid is collected and dried, 0.95 g, mp: 105 - 110 ° C, solidifies again and melts again at ca.

160° C. Ved omkrystallisation af benzen fås lysegule krystaller af l-(3,5-diamino-6-chlorpyrazinoyl)-3-benzyloxyguanidin, smp: 163 -166°C.160 ° C. Recrystallization of benzene gives pale yellow crystals of 1- (3,5-diamino-6-chloropyrazinoyl) -3-benzyloxyguanidine, mp: 163 -166 ° C.

Analyse beregnet for C^^H^ClN^Og: C 46,50, H 4,20, N 29,21.Analysis calculated for C C HH ^ClN ^ And: C 46.50, H 4.20, N 29.21.

Pundet: C 46,72, H 4,23, N 29,45.Pound: C 46.72, H 4.23, N 29.45.

Ved fremgangsmåden ifølge ovennævnte eksempler kan fremstilles følgende forbindelser: 1_(3,5-diamino-6-chlorpyrazinamido)guanidin, smp: 281 - 282 °c, l-(3,5-diamino-6-chlorpyrazinamido)-3-benzylguanidin, der bliver flydende ved 120 - 130° C, stivner igen red 200° C, og derpå har et smeltepunkt på 243 - 246°C (delt.), 1-(3,5-diamino-6~chlorpyrazinamido)-3-aminoguanidin-hydrat, smp: 196- 200 °C under opbrusning, og 1-(3,5-diamino-6-chlorpyrazinamido)-2,3-ethylenguanidin, smp: 250 - 251 °C, (dek.).By the method of the above examples, the following compounds can be prepared: 1 (3,5-diamino-6-chloropyrazinamido) guanidine, mp: 281 - 282 ° C, 1- (3,5-diamino-6-chloropyrazinamido) -3-benzylguanidine, which becomes liquid at 120-130 ° C, solidifies red again at 200 ° C and then has a melting point of 243 - 246 ° C (shared), 1- (3,5-diamino-6-chloropyrazinamido) -3-aminoguanidine hydrate, mp: 196-200 ° C while effervescent, and 1- (3,5-diamino-6-chloropyrazinamido) -2,3-ethylene guanidine, mp: 250 - 251 ° C (dec.).

Claims (2)

13 145892 P_a_t_e_n_t k r av :13 145892 P_a_t_e_n_t k r av: 1. Fremgangsmåde til fremstilling af pyrazinamidderivater med den almene formel: R1 XX e halo^ “ CONHR° hvori R^ er hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, (cycloalkylalkyl), dialkylaminoalkyl, hydroxyalkylmethyl, poly-hydroxyalkylmethyl ,iw, \}J, U/-trif luoralkyl, phenylalkyl, halogen-phenylalkyl, furylalkyl, phenyl, halogenphenyl, alkoxy eller amino; 0 R er hydrogen eller alkyl; eller 1A process for the preparation of pyrazinamide derivatives of the general formula: R 1 XX e halo ^ 'CONHR ° wherein R 2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, (cycloalkylalkyl), dialkylaminoalkyl, hydroxyalkylmethyl, polyhydroxyalkylmethyl, J, U / -trifluoroalkyl, phenylalkyl, halo-phenylalkyl, furylalkyl, phenyl, halophenyl, alkoxy or amino; O is hydrogen or alkyl; or 1 2 R og R kan tilsammen danne en azacyclisk ri'ng med det tilknyttede nitrogenatom; halo er chlor, brom eller iod; R® er alkyl, alkoxymethylalkyl, cyanoalkyl, alkoxycarbonylalkyl, phenylalkyl, dialkylaminomethylalkyl, 2-(2-imidazolinyl)amino- methylalkyl, 1-pyrrolidinylalkyl, piperidinoalkyl, hexahydro- 1-azeoinylalkyl, morpholinoalkyl, 4-alkyl-l-piperazinylalkyl, alkenyl, alkynyl, phenyl, halogenphenyl, alkylphenyl, alkoxy- phenyl, amino, dialkylamino, alkylphenylalkylamino, pyridylamino, pyrimidinylamino, quinolinylamino, 1-pyrrolidinyl, 1-piperidino, 1-hexahydro-1-azepinyl, 4-morpholino, 4-(3,5-diamino-l,2,4-tria-7 7 zolyl), -OR / hvor R er alkyl, phenyl, halogen- Ih phenyl, alkylphenyl eller alkoxyphenyl; 9 10 8 -C-NR R , hvor R er hydrogen eller alkyl; t8 g R er hydrogen, alkyl, hydroxyalkyl, phenylalkyl, halogenphenyl-alkyl, alkylphenylalkyl, naphthylalkyl, pyridylalkyl, morpholinoalkyl, furylalkyl, alkoxyalkyl, alkenyl, alkylidenamino, phenyl-alkylidenamino, hydroxy, phenyl, alkylphenyl, alkoxyphenyl, halogenphenyl, alkoxyphenylalkyl, alkoxy, phenylalkoxy;2 R and R may together form an azacyclic ring with the associated nitrogen atom; halo is chlorine, bromine or iodine; R 2 is alkyl, alkoxymethylalkyl, cyanoalkyl, alkoxycarbonylalkyl, phenylalkyl, dialkylaminomethylalkyl, 2- (2-imidazolinyl) aminomethylalkyl, 1-pyrrolidinylalkyl, piperidinoalkyl, hexahydro-1-azeoinylalkyl, morpholinoalkyl, 4-alkyl-alkyl, 4-alkyl-alkyl alkynyl, phenyl, halophenyl, alkylphenyl, alkoxyphenyl, amino, dialkylamino, alkylphenylalkylamino, pyridylamino, pyrimidinylamino, quinolinylamino, 1-pyrrolidinyl, 1-piperidino, 1-hexahydro-1-azepinyl, 4-morpholino -diamino-1,2,4-tria-7zolyl), -OR / where R is alkyl, phenyl, halo-1h phenyl, alkylphenyl or alkoxyphenyl; -C-NR R 9 wherein R is hydrogen or alkyl; t8 g R is hydrogen, alkyl, hydroxyalkyl, phenylalkyl, halophenylalkyl, alkylphenylalkyl, naphthylalkyl, pyridylalkyl, morpholinoalkyl, furylalkyl, alkoxyalkyl, alkenyl, alkylideneamino, phenylalkylideneamino, hydroxy, phenyl, alkylphenyl, alkoxyphenyl, alkoxyphenyl, alkoxyphenyl, alkoxyphenyl phenylalkoxy;
DK429268A 1967-09-07 1968-09-06 PROCEDURE FOR THE PREPARATION OF PYRAZINAMIDE DERIVATIVES DK145892C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66600467A 1967-09-07 1967-09-07
US66600467 1967-09-07
US71897668A 1968-03-21 1968-03-21
US71897668 1968-03-21

Publications (2)

Publication Number Publication Date
DK145892B true DK145892B (en) 1983-04-05
DK145892C DK145892C (en) 1983-09-12

Family

ID=27099350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK429268A DK145892C (en) 1967-09-07 1968-09-06 PROCEDURE FOR THE PREPARATION OF PYRAZINAMIDE DERIVATIVES

Country Status (15)

Country Link
AT (1) AT289123B (en)
BE (1) BE720233A (en)
CA (1) CA939345A (en)
CH (1) CH534168A (en)
DK (1) DK145892C (en)
ES (1) ES357877A1 (en)
FI (1) FI50975C (en)
FR (1) FR8490M (en)
GB (2) GB1214409A (en)
IL (1) IL30634A0 (en)
NL (1) NL6812003A (en)
NO (1) NO125678B (en)
OA (1) OA02886A (en)
SE (1) SE355811B (en)
YU (2) YU205268A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2854217C (en) 2011-11-02 2019-12-31 Boehringer Ingelheim International Gmbh Substituted pyrazinoylguanidine compounds and their use as epithelial sodium channel blockers, medicaments containing said compounds and processes for the preparation thereof
WO2013064451A1 (en) * 2011-11-02 2013-05-10 Boehringer Ingelheim International Gmbh Novel process for the preparation of acylguanidines and acylthioureas
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
WO2013174757A1 (en) 2012-05-25 2013-11-28 Boehringer Ingelheim International Gmbh Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
WO2014044849A1 (en) 2012-09-24 2014-03-27 Boehringer Ingelheim International Gmbh Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof

Also Published As

Publication number Publication date
IL30634A0 (en) 1968-10-24
NO125678B (en) 1972-10-16
GB1214408A (en) 1970-12-02
CA939345A (en) 1974-01-01
FI50975C (en) 1976-09-10
GB1214409A (en) 1970-12-02
CH534168A (en) 1973-02-28
YU205268A (en) 1978-06-30
AT289123B (en) 1971-04-13
NL6812003A (en) 1969-03-11
SE355811B (en) 1973-05-07
FR8490M (en) 1973-07-27
YU34082B (en) 1978-12-31
ES357877A1 (en) 1970-05-01
FI50975B (en) 1976-05-31
BE720233A (en) 1969-02-28
DK145892C (en) 1983-09-12
OA02886A (en) 1970-12-15

Similar Documents

Publication Publication Date Title
CA2559733C (en) Inhibitors of histone deacetylase
JP3179515B2 (en) Method for producing 2-chlorothiazoles
US4423045A (en) Thiadizines
HU220046B (en) Pyrazolopyrimidinone derivatives, pharmaceutical compositions containing them and process for their preparation
PL175831B1 (en) Pyrazoles and prazolopyrimidines exhibiting antagonistic activity in respect to crf
NO301929B1 (en) 4-aryl-thiazole or imidazole derivatives
US3041336A (en) 3-oxo-1.2.6-thiadiazine-1.1-dioxides
Senda et al. Pyrimidine derivatives and related compounds. 15. Synthesis and analgetic and antiinflammatory activities of 1, 3-substituted 5-amino-6-methyluracil derivatives
SU797577A3 (en) Method of preparing 3-(pyrazol-1-yl)-pyridazine derivatives or their pharmacetically employed salts
US6548512B1 (en) Nitrogen containing heteroaromatics as factor Xa inhibitors
JPH0959236A (en) Benzamide
Winn et al. 2-(Alkylamino) nicotinic acid and analogs. Potent angiotensin II antagonists
CS241039B2 (en) Method of new n-(2-(or 3)pyrrolidinyle(or pyrrolidinylmethyl)((-benzamides production,substituted in positions 2,3,4,5,6
Garratt et al. One-carbon compounds as synthetic intermediates. The synthesis of hydropyrimidines and hydroquinazolines by sequential nucleophilic addition to diphenyl cyanocarbonimidate with concomitant cyclization
Lazbin et al. N-phenyliodonio carboxamide tosylates: synthesis and hydrolysis to alkylammonium tosylates
Rozentsveig et al. Amidine derivatives of α-arylglycines from N-(1-aryl-2, 2, 2-trichloroethyl) amides of arenesulfonic acids and secondary amines
US4436913A (en) 1H- and 2H- indazole derivatives
DK145892B (en) PROCEDURE FOR THE PREPARATION OF PYRAZINAMIDE DERIVATIVES
NO138530B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-SUBSTITUTED PYRAZOLONE (5) DERIVATIVES
US3305553A (en) 2-aminoquinazoline derivatives
US4914104A (en) Imidazo [1,5-a]pyrimidine derivatives and process for their preparation
US4666915A (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same
EP0033614A1 (en) Phenylalkanoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
EP0008226A2 (en) Phenyl-alkanoic acid derivatives, the preparation thereof and pharmaceutical compositions containing them
Sianesi et al. New benzothiazines. 4. 1H-2, 3-Benzothiazin-4 (3H)-one 2, 2-dioxide and 2H-1, 2-benzothiazin-3 (4H)-one 1, 1-dioxide nitrogen derivatives with central nervous system activity